Larvol Delta - SAAKI-Phase-3-Study-of-Reltecimod-vs-Placebo-in-Patients-With-Sepsisassociated-Acute-Kidney-Injury

reltecimod (AB103) - Atox Bio

http://clinicaltrials.gov/ct2/show/NCT03403751

Aug 7, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next